Management of HER2-Altered Non-Small Cell Lung Cancer
Manage episode 355988621 series 2787983
Dr Bob Li from Memorial Sloan Kettering Cancer Center in New York City discusses the current and future roles of targeted therapy for HER2-altered non-small cell lung cancer.
CME information and select publications here.
199 episoder